Abstract
In recent studies, TMIGD2 has found that it may play an important role in a new therapeutic target in the process of accurate tumor treatment. High expression of TMIGD2 in HCC and glioma cancer can be used as a potential therapeutic target, and some studies showed that the expression level of TMIGD2 in thyroid cancer tissue is also higher than that in normal thyroid tissue, and its expression level is correlated with the malignancy and poor prognosis of tumors. These more cutting-edge findings suggest that TMIGD2 may be used as a potential target for the treatment of thyroid cancer for precise treatment. This article will introduce the current situation and development trend of TMIGD2 in the clinical precision treatment of thyroid cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
